Alzheimer's Disease: Treatment and Follow up

Treatment Options for Alzheimer's Disease

There is currently no cure for Alzheimer's disease. Available treatments can temporarily improve symptoms, slow the progression of the disease, and improve quality of life. Treatment requires a multidisciplinary approach.

Treatment includes medication, cognitive and behavioral interventions, supportive care, and lifestyle changes. Starting treatment in the early stages is most effective. The treatment plan is personalized according to the patient's stage, symptoms, and overall health status.

Medication Treatment

Approved medications for Alzheimer's treatment fall into two main categories: cholinesterase inhibitors and NMDA receptor antagonists.

• Cholinesterase inhibitors. These medications improve communication between brain cells by increasing acetylcholine levels. They are used in mild to moderate Alzheimer's. They can temporarily improve symptoms for 6-12 months but do not stop the progression of the disease.
• Cholinesterase inhibitors are generally started at a low dose and gradually increased to minimize side effects. Each patient may respond differently.
• Memantine (Namenda). This is an NMDA receptor antagonist approved for moderate to severe Alzheimer's. It regulates the excessive activity of a neurotransmitter called glutamate and reduces nerve cell damage. It can improve cognitive function, daily activities, and behavioral symptoms.
• Combination therapy. The combination of donepezil and memantine may be more effective than either medication alone in moderate to severe Alzheimer's.
• Medications for behavioral and psychological symptoms. As Alzheimer's progresses, agitation, hallucinations, depression, and anxiety may occur. Medications are available for these symptoms, but non-medication approaches (such as music therapy, activity programs, and environmental modifications) should be the first choice for managing behavioral symptoms.

Cognitive and Behavioral Therapies

Non-medication interventions are critically important in Alzheimer's management. These approaches improve quality of life and can reduce symptoms.

• Cognitive stimulation therapy. Cognitive function is stimulated through group activities and exercises. These include games, discussions, memory exercises, music, and art activities. It can temporarily improve memory and thinking skills and increases social interaction.
• Reminiscence therapy. Memory is stimulated by discussing past events, photographs, and music. Although short-term memory is impaired, long-term memory from the distant past is preserved for longer. This therapy improves mood and provides a sense of connection.
• Validation therapy. This approach involves acknowledging and accepting the patient's feelings and perceptions. Rather than trying to correct the patient, empathy is shown. It reduces agitation and builds trust.
• Music therapy. Listening to or playing music stimulates cognitive function, improves mood, and reduces agitation. Music memory is relatively preserved in Alzheimer's. Familiar songs can evoke strong emotional responses.
• Art and recreational therapies. Activities such as painting, sculpting, and gardening encourage creativity, provide purposeful engagement, and improve mood.
• Animal-assisted therapy. Interaction with pets reduces stress, increases social connection, and improves mood. Petting a dog or cat has a calming effect.
• Physical exercise. Regular physical activity helps preserve cognitive function, improves physical health, enhances sleep quality, and reduces behavioral symptoms. Walking, dancing, gardening, and light gymnastics are recommended. A goal of at least 150 minutes of moderate-intensity exercise per week should be aimed for.
• Structured daily routines. Consistent, predictable routines give the patient a sense of security and reduce confusion. Activities should be suited to the patient's abilities and provide a sense of accomplishment.

Supportive Therapies

• Nutritional support. A balanced diet supports brain health. The Mediterranean diet (fish, olive oil, vegetables, fruit, whole grains) is recommended. Vitamin and mineral supplements (B12, D, E) may be needed at low levels but are not recommended for routine use. In later stages, if swallowing is difficult, soft or pureed foods or caloric supplements may be required.
• Sleep hygiene. A regular sleep schedule, a comfortable sleep environment, and physical activity throughout the day improve sleep quality. To reduce nighttime wandering, limiting daytime naps and avoiding caffeine and alcohol in the evening are recommended.
• Social interaction. Family visits, social activities, and support groups reduce isolation and improve mood. Activities suited to the patient's interests (such as music, gardening, or crafts) are recommended.
• Safety measures. Home safety modifications (such as preventing slippery floors, ensuring good lighting, and removing sharp objects) reduce the risk of falls and injuries. GPS tracking devices help prevent the patient from getting lost. Assessing driving ability and, if necessary, revoking the driver's license is important.

Follow-up and Expectations After Treatment

Alzheimer's disease is chronic and progressive. Regular follow-up after treatment is necessary to evaluate medication effectiveness and prevent complications.

• Follow-up frequency. Check-ups every 3 months are recommended for the first 6 months. If the patient is stable, every 6 months may be sufficient thereafter. If symptoms worsen or a new medication is started, more frequent follow-up is needed. Cognitive tests are repeated, medication side effects are evaluated, and blood tests are checked at each visit.
• Evaluating medication effectiveness. The benefit of medications varies from person to person. Some patients show noticeable improvement, while others show minimal response. A medication is generally tried for 3-6 months; if no benefit is seen or side effects are severe, it is changed. However, rapid decline can occur after stopping a medication, so this decision should be made together with the doctor.
• Monitoring disease progression. Cognitive and functional decline is assessed annually. MMSE or MoCA tests are repeated. Daily living activities are evaluated. The disease stage is determined and the care plan is updated accordingly.
• Repeat brain imaging. Routine repeat brain MRI is not necessary. However, MRI may be repeated in cases of unexpectedly rapid decline, new neurological symptoms (suspected stroke), or in patients receiving anti-amyloid therapy (to monitor for ARIA).
• Updating the care plan. Care needs increase as the disease progresses. In the early stage, family support may be sufficient. In the middle stage, adult day care centers or in-home assistance may be needed. In the late stage, full-time care or nursing home placement may be considered. Palliative care services can assist with symptom management and end-of-life decisions.
• Outlook and prognosis. Alzheimer's disease is progressive and currently cannot be stopped or reversed. Average life expectancy after diagnosis is 4-8 years, but there is wide variation (2-20 years). The rate of progression varies from person to person. Those with earlier onset generally progress more quickly.
• Treatment can improve symptoms and quality of life but cannot completely stop the progression of the disease. New anti-amyloid treatments are promising but their effects are modest (20-30% slowing). More effective treatments are expected to be developed in the future.
• Quality of life. With appropriate treatment, support, and care, people with Alzheimer's can live meaningful lives. Family connections, music, nature, and beloved activities enhance quality of life. The focus should be on overall well-being and dignity, not just cognitive function.